Floatz logo

Omacetaxine

Age ≥60

First Affiliated Hospital of Zhejiang UniversityPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the Age ≥60 cohort.

Asset / SponsorPhaseRating
Cladribine
First Affiliated Hospital of Zhejiang University
Phase 2CCC
Venetoclax
First Affiliated Hospital of Zhejiang University
Phase 2CCC
Cytosin-Arabinosid
First Affiliated Hospital of Zhejiang University
Phase 2CCC
Azacitidine
First Affiliated Hospital of Zhejiang University
Phase 2CCC

Same molecule, other indications

Omacetaxine is also rated in:

Acute Myeloid Leukaemia; Myelodysplastic Syndromes;Chronic Myelomonocytic LeukemiaDormant
BB
Indicative ·
65 / 100
View asset →
Elderly Patients (60-75 Years)Dormant
B
Indicative ·
60 / 100
View asset →
Induction ChemotherapyDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →